Pharma doctor spend pays off for branded scripts

Doctors receiving payments were almost twice as likely to prescribe three brand name gabapentinoids, study shows

Paying doctors speaker fees or shouting them a meal appear to have paid off for the marketers of brand name gabapentinoids, US research suggests.

pharmaceutical drug companies

Doctors who received pharma company payments were almost twice as likely to prescribe the branded versions of  the drugs than those who received no money, says a research letter in JAMA Internal Medicine.

Researchers from Yale University and the University of Connecticut examined the association between pharma payments and physician